Singapore markets closed
Straits Times Index
3,257.18 -5.36 (-0.16%) S&P 500
4,056.03 +28.22 (+0.70%) Dow
32,841.60 +124.00 (+0.38%) Nasdaq
12,029.55 +103.31 (+0.87%) Bitcoin USD
28,530.29 +128.60 (+0.45%) CMC Crypto 200
620.09 +0.85 (+0.14%)
ABBV Jan 2025 110.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:56PM EDT. Market open.
| Previous close | 50.90 |
| Open | 50.90 |
| Bid | 50.65 |
| Ask | 51.55 |
| Strike | 110.00 |
| Expiry date | 2025-01-17 |
| Day's range | 50.90 - 50.90 |
| Contract range | N/A |
| Volume | |
| Open interest | 98 |
- Motley Fool
2 High-Yielding Dividend Investments to Buy for the Long Haul
Both of these stocks are Dividend Kings, and their payouts are likely to continue rising in the future.
- Motley Fool
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
Vertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market. Vertex and AbbVie also happen to offer a lot of growth potential. Vertex has a new potential blockbuster drug on the horizon.
- Motley Fool
Better Growth Stock: AbbVie vs. Pfizer
AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two of the world's biggest pharmaceutical companies, and the similarities don't end there. The case for AbbVie as a growth stock can't avoid two issues: the decline of Humira, and the stagnation of its oncology portfolio.
© 2023 Yahoo. All rights reserved.
